Lynn Shapiro Snyder is a senior health care regulatory lawyer and strategic advisor for health care and life sciences companies.
She has over 40 years of experience at Epstein Becker Green navigating clients through health care regulatory, reimbursement (Medicare, Medicaid, commercial), billing, health policy challenges, health care mergers and acquisitions, and health care fraud enforcement, including anti-kickback and false claims investigations (DOJ/qui tam cases / DHHS OIG / state Medicaid Fraud Control Units). Lynn’s clients include all types of health care and life sciences companies, vendors serving health care companies that are focused on the U.S. market, as well as private equity and venture capital firms investing in such companies. She is the Founder and Chair of the Board of the Women Business Leaders of the U.S. Health Care Industry Foundation. Lynn also advises on enterprise risk management arising from her board work for Epstein Becker Green and WBL and from her other outside board positions.
Lynn has advised and defended a wide range of health care providers, payers, and vendors in connection with federal and state health care fraud enforcement actions. She has conducted many internal investigations and advocated for many clients before DOJ / DHHS OIG / state Medicaid Fraud Control Units. In doing so, Lynn has been a leader in crafting new corporate integrity obligations for new areas of enforcement. Lynn also has served as a government-approved monitor for compliance monitor contractual obligations, including being a monitor for an electronic health record vendor.
Additionally, Lynn has advised on commercialization strategies and compliance related to artificial intelligence, digital health (including prescription digital therapeutics), and telemedicine. Lynn advises clients on strategies for Medicare, Medicaid, TRICARE, VA, and commercial payors. She also has extensive experience providing comprehensive strategies to medical device and pharmaceutical manufacturers on coding, coverage, payment, and reimbursement issues under Medicare, Medicaid, and with commercial payors. Besides coding, coverage, and payment issues, areas of Lynn’s counsel include new payment methods, such as accountable care and pay for value, as well as HCPCS codes, CPT codes, J codes, and Q codes. Lynn also advises clients on new legislation, such as the Cures Act, the Inflation Reduction Act, and the No Surprises Acts.
One of the earliest health care lawyers—and one of the first women in the field—Lynn has guided the strategic growth of leaders and innovators in the health care industry. She uses a deep professional network to cut red tape, prevent costly missteps, and keep deals on track. Her practical, well-timed insights inform the big-picture solutions clients need in government inquiries, product launches, corporate mergers, and more.
Clients count on Lynn’s future-thinking to identify their risks and rewards in a dynamic business and regulatory climate, including health care reform and the impact of new consumerism. To strengthen clients’ enterprises, Lynn discovers best-in-class practices during annual business missions visiting non-U.S. health systems—Belgium 1995, Israel 1997, Brazil 1999, Italy 2002, Argentina 2005, Czech Republic 2006, Ireland 2008, Chile 2009, France 2010, Great Britain 2012, the Netherlands 2013, Israel 2014, Scotland 2015, Denmark 2016, Germany 2017, and Sweden 2019. In addition, she leads international health care companies in gaining a U.S. foothold.
Lynn’s long-lived commitment to health care clients started with working in her family’s retail pharmacy / home medical equipment business and extends today to service on boards of directors. A champion of inclusion, Lynn founded the Women Business Leaders of the U.S. Health Care Industry Foundation™(WBL). Her 20-year leadership has resulted in WBL’s strong, growing industry network and numerous appointments of women to corporate boards.
Lynn holds several leadership positions within Epstein Becker Green, including as a member of its Board of Directors and as Vice Chair of the Finance Committee, and is cofounder of the firm’s Health Employment and Labor (HEAL®) strategic industry group. She is also Strategic Counsel with EBG Advisors, Inc., and National Health Advisors. Additionally, Lynn frequently speaks and writes on the subjects of health reform, enterprise risk, and compliance. She authored Advancing Women in Business: 10 Best Practices and co-authored Answering the Call: Understanding the Duties, Risks and Rewards of Corporate Governance.
Lynn represented several health trade associations during the enactment of the 1977 Medicare Anti-Fraud and Abuse Amendments and the 1978 HMO Amendments. She has served as a member of (1) the State of Florida Agency for Health Care Administration Health Care Fraud and Abuse Working Group (1993-1994) and (2) the Study Panel on Reforming the Fee-for-Service Medicare Program, sponsored by the National Academy of Social Insurance (1996-1998). Lynn represented the American Hospital Association in drafting the legislation for the Medicare Prospective Payment (“DRG”) System (1982).
- Artificial Intelligence
- Behavioral Health
- Corporate Financing
- Corporate Governance
- Cross-Border Transactions
- Digital Health
- Drug and Medical Device Coding, Coverage, and Payment
- Federal and State False Claims Act (Including Qui Tam)
- Foreign Multinational Counseling and Litigation
- Fraud and Abuse Compliance Counseling and Defense
- Government and Commercial Coding, Coverage, and Payment
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Health Care and Life Sciences Investor Services
- Health Care Mergers and Acquisitions
- Health Policy and Legislation
- Life Sciences
- Life Sciences Due Diligence
- Mergers, Acquisitions & Divestitures
- Value-Based Purchasing and Accountable Care
- White Collar Defense and Internal Investigations
- Artificial Intelligence
- Health Care Industry
- Health Plans and Other Insurers
- Home Health, Hospice & Community-Based Providers
- Hospitals and Health Systems
- Investment Banks & Private Equity
- Life Sciences Industry
- Medical Devices
- Post-Acute and Long-Term Care Providers
- Suppliers & Distributors
- Serves as lead health care deal counsel for private equity firms and strategic partners, including as lead health regulatory counsel for the buyout of HCA by three private equity firms; the buyout of Biomet; and the creation of Ascensia globally, among many others.
- Leads the defense of claims of health care fraud in Medicare/Medicaid False Claims Act investigations and litigation at the federal and state levels. Lynn has defended one of the largest pharmaceutical firms, one of the largest home health service firms, and one of the largest respiratory services firms.
- Counsels all types of health care providers, including payors and pharmaceutical and medical device manufacturers. Lynn has advised on regulatory requirements for clients’ innovations in telemedicine and artificial intelligence.
- Advises clients on strategies for Medicare, Medicaid, TRICARE, VA, and commercial payors. Areas of Lynn’s counsel also include coding, coverage, and payment issues and new payment methods, such as accountable care and pay for value, as well as HCPCS codes, CPT codes, J codes, and Q codes.
- Represents national and state health care trade associations on policy issues and trends, including drafting federal and state legislation, advocacy documents, and studies to support policy positions.
- Harvard T.H. Chan School of Public Health, Executive and Continuing Professional Education
- Innovation with AI in Health Care (May 2023)
- Northwestern University Kellogg School of Management
- Women Director Development Program (July 31 to August 2, 2002)
- The George Washington University Law School (J.D., 1979)
- Franklin & Marshall College (A.B., magna cum laude, 1976)
- Phi Beta Kappa
- Economics with Health Economics concentration
- District of Columbia
- New York
- Supreme Court of the United States
- U.S. Court of Appeals for the Eleventh Circuit
Board of Directors
- AMCP (American Managed Care Pharmacy) Foundation (former)
- Apria Healthcare (2019 to 2022) (Blackstone Portfolio Company)
- Epstein Becker & Green, P.C. (2007 to present)
- Magnolia Holdings/PT Solutions (2023 to present) (General Atlantic Portfolio Company)
- Maryland/Israel Development Center (former)
- Nashville Health Care Council (2021 to 2023)
- National Hospice Foundation (former)
- Trustmark Mutual Holding Company (2006 to present)
- Women Business Leaders of the U.S. Health Care Industry Foundation, Inc. (2000 to present)
Board of Advisors
- TPG International Health Academy (former)
- Benjamin Rush Society, Franklin and Marshall College (former)
- BNA Health Care Fraud Reporter (former)
- BNA Health Insurance Report Advisory Board (former)
- Harvard School of Public Health Policy and Management Executive Council (former)
- HelpAround (former)
- Primex Wireless (former)
- Protocare Sciences, Advisory Board (former)
- Savor Health (former)
Professional & Community Involvement
- Women Business Leaders of the U.S. Health Care Industry Foundation
- American Health Lawyers Association
- Food and Drug Law Institute
- Health on Wednesday, a group of Women Health Policy Experts, Founding Member
- October 24, 2022
- Wound Care Evidence Summit 2022: Challenges and Opportunities in Wound Care Research, Clinical Care and CoverageMay 19, 2022
- The Florida Bar Board of Legal Specialization & Education, Board Certified in Health Law (1998 to Present)
Health Care Industry Recognition
- Modern Healthcare, “100 Most Powerful People in Healthcare,” inaugural issue (August 2002)
- Modern Healthcare, Top 25 Women in Healthcare (2005)
- Jewish Women International, Women to Watch Award (2007)
Legal Industry Recognition
- The Best Lawyers in America, Health Care Law (2006 to 2024)
- Chambers USA: The World's Leading Lawyers for Business, District of Columbia—Healthcare, Band 1 (2006 to 2023)
- The Legal 500 United States, Healthcare: Advice to Health Insurers (2014, 2016, 2018 to 2023), Advice to Service Providers (2023)
- Martindale-Hubbell, AV Preeminent Rated
- Nightingale's Healthcare News, “Outstanding Fraud & Compliance Lawyers for 2006”
- Washington, DC, Super Lawyers, Health Care (2007 to 2023)
- Who’s Who Legal, Healthcare (2020)